http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114409824-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0003 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00 |
| filingDate | 2022-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-114409824-B |
| titleOfInvention | Mucor exopolysaccharide and its preparation method and application |
| abstract | The present invention provides Mucor sp. exopolysaccharide and its preparation method and application. Compared with the prior art, the present invention extracts exopolysaccharide from Mucor sp. fermentation liquid by ethanol precipitation method; the prepared cell The weight-average molecular weight of exopolysaccharide is 7.78×10 4 Da, mainly composed of mannose, galactose, fucose, arabinose and glucose, and the molar ratio is 0.466:0.169:0.139:0.126:0.015. The exopolysaccharide prepared by the present invention inhibits the proliferation of human gastric adenocarcinoma cell SGC-7901 in a dose-dependent manner, and exerts anti-tumor activity by inducing apoptosis of SGC-7901 cells; it can be used to prepare drugs for treating tumors, especially for the preparation of Application of drugs for inhibiting the proliferation of gastric cancer cells. |
| priorityDate | 2022-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 107.